Organogenesis Holdings Inc. Class A Common Stock (ORGO) Stock
NASDAQ · ORGO
Key stats
- Market cap
- $136.29M
- Price / Earnings ratio
- -0.8x
- EPS (TTM)
- -$1.18
- Volume
- Loading
- 52-week high
- $7.08
- 52-week low
- $0.73
Source: third-party data provider, as of November 13, 2026
Compare with ORGO
Recent news

MarketBeat
Organogenesis Q2 Earnings Call Highlights
ORGOAugust 7, 2026
MarketBeat
Organogenesis Q2 Earnings Call Highlights
ORGO

MarketBeat
Organogenesis Q1 Earnings Call Highlights
ORGOMay 8, 2026
MarketBeat
Organogenesis Q1 Earnings Call Highlights
ORGO

Stocktwits
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
ORGOApril 6, 2026
Stocktwits
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
ORGO

Zacks Investment Research
Best Momentum Stocks to Buy for January 5th
ORGOJanuary 5, 2024
Zacks Investment Research
Best Momentum Stocks to Buy for January 5th
ORGO
Technical indicators
- RSI 14
- 52.51
- MACD 12/26/9
- -0.09
- EMA 9 of MACD
- -0.13
- MACD histogram
- 0.04
- SMA 50
- $1.22
- Price below SMA 50
- EMA 50
- $1.22
- Price below EMA 50
- SMA 200
- $2.25
- Price below SMA 200
- EMA 200
- $2.39
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
677M447M223M0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
718M474M237M0
Revenue to Profit
2025$564.2M
Revenue$0.0
Cost of revenue$426.6M
Gross profit$0.0
Operating expenses$37.0M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

MarketBeat
Organogenesis Q2 Earnings Call Highlights
ORGOAugust 7, 2026
MarketBeat
Organogenesis Q2 Earnings Call Highlights
ORGO

MarketBeat
Organogenesis Q1 Earnings Call Highlights
ORGOMay 8, 2026
MarketBeat
Organogenesis Q1 Earnings Call Highlights
ORGO

Stocktwits
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
ORGOApril 6, 2026
Stocktwits
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
ORGO

Zacks Investment Research
Best Momentum Stocks to Buy for January 5th
ORGOJanuary 5, 2024
Zacks Investment Research
Best Momentum Stocks to Buy for January 5th
ORGO

Zacks Investment Research
New Strong Buy Stocks for January 5th
ORGOJanuary 5, 2024
Zacks Investment Research
New Strong Buy Stocks for January 5th
ORGO

CNBC
TipRanks reveals the top 10 health care sector analysts of the past decade
ORGOMay 21, 2023
CNBC
TipRanks reveals the top 10 health care sector analysts of the past decade
ORGO
About Organogenesis Holdings Inc. Class A Common Stock
No description available.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees854
CEOMr. Gary S. Gillheeney Sr.
IPO DateJan 5, 2017
HeadquartersCanton, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Gary S. Gillheeney Sr. | President, CEO, Chair of the Board | 1955 |
| Mr. David C. Francisco | Chief Financial Officer | 1966 |
| Mr. Patrick Bilbo | Chief Operating Officer | 1962 |
| Ms. Lori H. Freedman B.A., Esq., J.D. | Chief Administrative & Legal Officer | 1967 |
| Mr. Brian Grow | Chief Commercial Officer | 1976 |
| Mr. Patrick McGuire | Chief Accounting Officer | 1986 |
| Mr. Robert Cavorsi | Chief Business Officer | 1979 |
| Mr. William R. Kolb CPA | Secretary | — |
Fundamentals
Valuation
Price-to-sales ratio0.22
Price-to-book value1.01
Profitability
Return on Equity-75.00%
Return on Assets-32.00%
Return on Sales-24.00%
Gross margin (latest quarter)51.83%
EBITDA$-53.30M
Trading
Average volume1,132,051
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 52.51
- MACD 12/26/9
- -0.09
- EMA 9 of MACD
- -0.13
- MACD histogram
- 0.04
- SMA 50
- $1.22
- Price below SMA 50
- EMA 50
- $1.22
- Price below EMA 50
- SMA 200
- $2.25
- Price below SMA 200
- EMA 200
- $2.39
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -6.9 | -6.3 | ||||||||||
| 2022 | -19.6 | +0.5 | +5.2 | -18.4 | -15.9 | -11.3 | +14.8 | -37.0 | -11.7 | +0.6 | -18.5 | -1.8 |
| 2023 | -1.9 | -6.8 | -6.6 | -4.2 | +80.6 | -9.8 | +27.5 | -34.7 | +9.3 | -24.6 | +11.4 | +49.8 |
| 2024 | -19.1 | +4.1 | -2.7 | -16.1 | +9.6 | +7.7 | +11.9 | +3.6 | +4.8 | -1.8 | +39.2 | -17.1 |
| 2025 | +21.5 | +82.1 | -20.1 | +14.7 | -44.8 | +37.6 | +22.2 | +14.2 | -13.9 | +0.2 | +29.5 | +2.0 |
| 2026 | -13.8 | -24.1 | -21.0 | +1.7 | +0.0 | +3.0 | -2.9 | -26.5 | -16.0 | -45.0 | +38.2 |
Compare stocks
Market cap
$136.29M
-
-
-
Price / Earnings ratio
-0.80
-
-
-
Price / Sales ratio
0.22
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
1,132,051
-
-
-
Earnings per share
$-1.18
-
-
-



